Exact Mass: 339.2925842
Exact Mass Matches: 339.2925842
Found 84 metabolites which its exact mass value is equals to given mass value 339.2925842,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
evocarpine
Evocarpine is a member of quinolines. Evocarpine is a natural product found in Tetradium ruticarpum with data available. 1-methyl-2-[(E)-tridec-8-enyl]quinolin-4-one is a natural product found in Tetradium ruticarpum with data available. Evocarpine, a quinolone alkaloid that could be isolated from Evodiae fructus, inhibitss Ca2+ influx through voltage-dependent calcium channels. Antimycobacterial activity[1][2]. Evocarpine, a quinolone alkaloid that could be isolated from Evodiae fructus, inhibitss Ca2+ influx through voltage-dependent calcium channels. Antimycobacterial activity[1][2].
Oleoyl glycine
C20H37NO3 (339.27732920000005)
N-oleoyl glycine is an acylglycine with oleoic acid (C18:1(9Z))moiety attached to glycine molecule. It is reported to be preferentially produced by human glycine N-acyltransferase-like 2 (hGLYATL2), a member of a gene family of 4 putative glycine conjugating enzymes, synthesizes various N-acyl glycines. Recombinantly expressed hGLYATL2 efficiently conjugated oleoyl-CoA, arachidonoyl-CoA, and other medium- and long-chain acyl-CoAs to glycine. The enzyme was specific for glycine as an acceptor molecule. N-oleoyl glycine is an acylglycine with oleoic acid (C18:1(9Z))moiety attached to glycine molecule N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte.
N-Oleoyl Glycine
C20H37NO3 (339.27732920000005)
N-oleoyl glycine, also known as MK-0518, raltegravirum, or isentress belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Glycine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Glycine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Glycine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
(Z)-1-Methyl-2-(tridec-8-en-1-yl)quinolin-4(1H)-one
2-acetamido-3-acetoxyhexadec-15-ene|diacetyl obscuraminol F
C20H37NO3 (339.27732920000005)
(9Z)-2-acetamido-3-acetoxyhexadec-9-ene|diacetyl obscuraminol D
C20H37NO3 (339.27732920000005)
N-Hexadecanoyl-(S)-3-Aminodihydro-2-furanone
C20H37NO3 (339.27732920000005)
(11Z)-2-acetamido-3-acetoxyhexadec-11-ene|diacetyl obscuraminol E
C20H37NO3 (339.27732920000005)
N-Hexadecanoyl-DL-homoserine lactone
C20H37NO3 (339.27732920000005)
N-hexadecanoyl-L-Homoserine lactone
C20H37NO3 (339.27732920000005)
EMA-1
C20H37NO3 (339.27732920000005)
N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte.
Rociverine
C20H37NO3 (339.27732920000005)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
4-(diethylamino) (2-dodecenyl)-4-oxo-Butanoic acid
C20H37NO3 (339.27732920000005)
5-oxopenta-1,3-dien-1-olate,tetrabutylazanium,hydrate
C21H41NO2 (339.31371260000003)
1-Dodecanaminium, N,N,N-trimethyl-, methyl sulfate
N-[dimethylamino-ethylimino-[[tris(dimethylamino)-λ5-phosphanylidene]amino]-λ5-phosphanyl]-N-methylmethanamine
Benzododecinium chloride
C21H38ClN (339.26926180000004)
D013501 - Surface-Active Agents > D003902 - Detergents > D001548 - Benzalkonium Compounds C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents D004202 - Disinfectants
cetylpyridinium chloride
C21H38ClN (339.26926180000004)
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D001697 - Biomedical and Dental Materials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-(1-Hydroxypropan-2-YL)octadec-9-enamide
C21H41NO2 (339.31371260000003)
N-[(3S)-Tetrahydro-2-oxo-3-furanyl]hexadecanamide
C20H37NO3 (339.27732920000005)
(15S)-hydroperoxy-(11Z,13E)-eicosadienoate
C20H35O4- (339.25352100000003)
(5S)-hydroperoxy-(6E,8Z)-eicosadienoate
C20H35O4- (339.25352100000003)
(Z,Z)-dicyclopropyl-methoxymycolate
C20H35O4- (339.25352100000003)
10,11-epoxy-12-hydroxy-(14Z)-eicosenoate
C20H35O4- (339.25352100000003)
12-hydroperoxy-(10E,14Z)-eicosadienoate
C20H35O4- (339.25352100000003)
14,15-epoxy-12-hydroxy-(10E)-eicosenoate
C20H35O4- (339.25352100000003)
N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]octanamide
C20H37NO3 (339.27732920000005)
N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]hexanamide
C20H37NO3 (339.27732920000005)
N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]propanamide
C20H37NO3 (339.27732920000005)
N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]acetamide
C20H37NO3 (339.27732920000005)
N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]pentanamide
C20H37NO3 (339.27732920000005)
N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]butanamide
C20H37NO3 (339.27732920000005)
N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]heptanamide
C20H37NO3 (339.27732920000005)
(Z)-N-(2-hydroxyethyl)nonadec-9-enamide
C21H41NO2 (339.31371260000003)
2-(2-Amino-2-methylpropyl)-1-methyl-3-(2,2,6,6-tetramethyl-1,2,3,6-tetrahydro-4-pyridyl)indole
2-(2-Amino-2-methylpropyl)-3-(1,2,2,6,6-pentamethyl-1,2,3,6-tetrahydro-4-pyridyl)indole
N-Oleoylglycine
C20H37NO3 (339.27732920000005)
A fatty acid derivative that is the 9Z-octadecenoyl derivative of glycine. It is believed to be an intermediate in oleamide biosynthesis. N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte.
Behenate
A straight-chain saturated fatty acid anion that is the conjugate base of behenic acid, arising from deprotonation of the carboxylic acid group.
fatty acid anion 22:0
Any saturated fatty acid anion containing 22 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.
n-[(2s,3r)-3-(acetyloxy)hexadec-15-en-2-yl]ethanimidic acid
C20H37NO3 (339.27732920000005)
13-[1-(1,3-oxazolidin-2-yl)pyrrolidin-2-yl]tridecan-2-amine
C20H41N3O (339.32494560000004)
1-methyl-2-[(z)-7-teidecenyl]-4-(1h)-quinolone
{"Ingredient_id": "HBIN002761","Ingredient_name": "1-methyl-2-[(z)-7-teidecenyl]-4-(1h)-quinolone","Alias": "NA","Ingredient_formula": "C23H33NO","Ingredient_Smile": "CCCCCC=CCCCCCCC1=CC(=O)C2=CC=CC=C2N1C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31674","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-methyl-2-[(z)-7-tridecenyl]-4(1h)-quinolone
{"Ingredient_id": "HBIN002762","Ingredient_name": "1-methyl-2-[(z)-7-tridecenyl]-4(1h)-quinolone","Alias": "NA","Ingredient_formula": "C23H33NO","Ingredient_Smile": "CCCCCC=CCCCCCCC1=CC(=O)C2=CC=CC=C2N1C","Ingredient_weight": "339.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16714","TCMID_id": "14733","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5319779","DrugBank_id": "NA"}
n-[3-(acetyloxy)hexadec-15-en-2-yl]ethanimidic acid
C20H37NO3 (339.27732920000005)
n-[(2s,3r,9z)-3-(acetyloxy)hexadec-9-en-2-yl]ethanimidic acid
C20H37NO3 (339.27732920000005)
n-[3-(acetyloxy)hexadec-9-en-2-yl]ethanimidic acid
C20H37NO3 (339.27732920000005)
1,13,17,17-tetramethyl-9-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7-trien-16-ol
(2e,4e,8e,10z,14z)-n-(2-methylbutyl)octadeca-2,4,8,10,14-pentaen-12-ynimidic acid
(1r,2s,10s,12s,13r,16r,18r)-1,13,17,17-tetramethyl-9-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7-trien-16-ol
n-[3-(acetyloxy)hexadec-11-en-2-yl]ethanimidic acid
C20H37NO3 (339.27732920000005)
3-[2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propan-1-ol
n-[(2s,3r,11z)-3-(acetyloxy)hexadec-11-en-2-yl]ethanimidic acid
C20H37NO3 (339.27732920000005)
(2r,3r,6r)-2-methyl-6-(11-oxododecyl)piperidin-3-yl acetate
C20H37NO3 (339.27732920000005)
2-methyl-6-(11-oxododecyl)piperidin-3-yl acetate
C20H37NO3 (339.27732920000005)